V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010789 | 190006408 | null | 68 | Curative (C) | 2020-03-07 | 2020-05-21 | EW EuroEwing 2012 Arm B IE | 01 | null | EW EUROEWING 2012 ARM B IE | 101446517 |
| 190010797 | 190006409 | 1.67 | 49 | null | 2018-11-08 | 2019-04-24 | PAM x 2 pre-surgery (cycles 1&2) | 02 | Y | EURAMOS TRIAL | 101477224 |
| 190010798 | 190006410 | 1.88 | 40 | Curative (C) | 2016-10-12 | 2016-10-12 | ECX | 02 | Y | EURAMOS TRIAL | 100833984 |
| 190010800 | 190006411 | 1.6 | 79.4 | null | 2017-04-21 | 2017-04-29 | ETOPOSIDE + IFOSFAMIDE | null | N | ETOPOSIDE + IFOSFAMIDE | 100086834 |
| 190010810 | 190006412 | 1.72 | null | Adjuvant (A) | 2018-01-24 | 2018-05-07 | LANREOTIDE | 02 | null | EW EUROEWING 2012 ARM A VAI | 100170944 |
| 190010819 | 190006413 | 1.74 | 69 | null | 2017-12-22 | 2018-09-03 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | DOXORUBICIN + METHOTREXATE | 101493385 |
| 190010837 | 190006414 | 1.6 | 81.8 | Curative (C) | 2018-02-01 | 2018-07-31 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101586453 |
| 190010845 | 190006415 | 1.79 | 81 | Curative (C) | 2018-06-08 | 2018-12-02 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100311643 |
| 190010850 | 190006416 | 1.65 | 88.4 | Curative (C) | 2018-11-11 | 2018-12-16 | Trial Unspecified | 02 | N | MAP + MIFAMURTIDE | 100033451 |
| 190010853 | 190006417 | 1.83 | 24.9 | Adjuvant (A) | 2017-03-16 | 2017-04-05 | Methotrexate Intermed dose (1g/m2) | null | null | METHOTREXATE | 100377460 |
| 190010854 | 190006418 | 1.83 | 76 | Curative (C) | 2017-09-30 | 2018-03-01 | Cyclophosphamide High Dose | 02 | N | DOXORUBICIN + METHOTREXATE | 100789276 |
| 190010858 | 190006419 | 1.66 | 75 | Curative (C) | 2014-11-16 | 2014-11-16 | GemCarbo Days 1+8 | 02 | N | ETOPOSIDE | 101419259 |
| 190010859 | 190006420 | 1.75 | 69 | Palliative (P) | 2020-09-30 | 2020-10-19 | Ifosfamide | 02 | null | METHOTREXATE HIGH DOSE | 100146635 |
| 190010862 | 190006421 | 1.63 | 11 | null | 2019-04-26 | 2019-12-25 | Capecitabine (21 day) + Irinotecan | 1 | Y | EURO-EWING | 100176446 |
| 190010868 | 190006422 | 1.69 | 98.4 | Palliative (P) | 2016-03-27 | 2016-09-09 | FLUOROURACIL + OXALIPLATIN | 01 | N | CISPLATIN + CYTARABINE | 100206002 |
| 190010872 | 190006423 | 1.75 | 59.2 | Palliative (P) | 2017-07-14 | 2017-07-22 | Melphalan IV High dose | 02 | Y | IRINOTECAN + TEMOZOLOMIDE | 101389407 |
| 190010881 | 190006424 | 0 | 38.3 | Palliative (P) | 2019-02-10 | 2019-02-11 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101581794 |
| 190010887 | 190006425 | 1.76 | 66 | Neo-adjuvant (N) | 2016-08-30 | 2016-08-30 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101753075 |
| 190010888 | 190006426 | 1.67 | 91.8 | Curative (C) | 2017-04-23 | 2017-04-24 | EW EuroEwing 2012 Arm A VAC | 02 | N | CISPLATIN + DOXORUBICIN | 101759564 |
| 190010889 | 190006427 | null | 89.6 | Curative (C) | null | 2021-05-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | EW EUROEWING 2012 ARM A VAI | 101177069 |
| 190010903 | 190006428 | 1.63 | 45 | Curative (C) | 2018-09-27 | 2018-10-30 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101580678 |
| 190010905 | 190006429 | 0 | 29.2 | null | 2016-11-14 | 2017-04-21 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 100829799 |
| 190010914 | 190006430 | 1.67 | 78.4 | null | 2017-09-09 | 2017-09-16 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 101520353 |
| 190010921 | 190006431 | 1.69 | 95.9 | Palliative (P) | 2019-03-13 | 2019-03-23 | CISPLATIN + RT | 02 | N | CAV | 100443179 |
| 190010926 | 190006432 | 1.58 | 62 | Neo-adjuvant (N) | 2020-08-25 | 2020-08-28 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 101195027 |
| 190010928 | 190006433 | 1.82 | 34.9 | Palliative (P) | 2021-06-17 | 2021-09-22 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 101391675 |
| 190000680 | 190006435 | 1.67 | 94.3 | Palliative (P) | 2016-10-13 | 2016-10-22 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101671483 |
| 190000808 | 190006436 | null | 69.8 | null | 2020-04-19 | 2020-04-25 | null | 02 | N | EURAMOS TRIAL | 101186648 |
| 190002742 | 190006437 | 0 | 62.6 | null | 2019-05-06 | 2019-08-03 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100678585 |
| 190003001 | 190006438 | 0 | 72.6 | null | 2018-10-16 | 2019-04-05 | PACLITAXEL | 02 | null | EW EUROEWING 2012 ARM B VDC | 101520261 |
| 190003789 | 190006439 | 1.57 | 60.9 | null | 2017-12-26 | 2018-06-25 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101294712 |
| 190003862 | 190006440 | 0 | 43.8 | Curative (C) | 2019-11-08 | 2019-12-06 | EURO-EWING | 02 | N | TRIAL | 100394493 |
| 190004140 | 190006441 | 1.76 | 89 | Palliative (P) | 2019-01-22 | 2019-01-26 | GEMCARBO | 02 | N | OST MIFAMURTIDE | 101394150 |
| 190004163 | 190006442 | 1.85 | null | Neo-adjuvant (N) | 2016-08-08 | 2017-03-10 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101625605 |
| 190004933 | 190006444 | 1.61 | 96.5 | null | 2020-06-09 | 2020-06-10 | GEMCITABINE | 01 | N | CYCLOPHOSPHAMIDE | 100493281 |
| 190005536 | 190006445 | 1.79 | 48.4 | Palliative (P) | 2018-07-28 | 2018-09-03 | EW EuroEwing 2012 Arm A VAI | 02 | null | EURAMOS TRIAL | 100026062 |
| 190005990 | 190006446 | 1.61 | 90.8 | Curative (C) | 2018-03-15 | 2018-03-18 | Trial Unspecified | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100280697 |
| 190006089 | 190006447 | 0 | 0 | Curative (C) | 2017-05-29 | 2017-12-17 | OST Euramos 1 Closed Trial - IE | 02 | null | ETOPOSIDE | 100145043 |
| 190006316 | 190006448 | 0 | 60.4 | Adjuvant (A) | 2019-02-04 | 2019-10-01 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101717386 |
| 190006487 | 190006450 | 0 | 24 | Curative (C) | 2017-04-26 | 2017-12-14 | EW EuroEwing 2012 Arm B VDC/IE | 02 | null | ETOPOSIDE | 101098407 |
| 190006530 | 190006451 | 1.64 | 67.7 | Palliative (P) | 2018-01-16 | 2018-01-16 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100393769 |
| 190006786 | 190006453 | 1.58 | 36 | Disease modification (D) | 2017-07-13 | 2017-08-09 | OST Euramos 1 Closed Trial - A | N | N | OST A | 100307503 |
| 190006894 | 190006454 | 0 | 64.8 | null | 2019-07-21 | 2020-01-28 | ETOPOSIDE + IFOSFAMIDE + METHOTREXATE | 02 | Y | NOT MATCHED | 101097341 |
| 190007060 | 190006455 | 0 | 68.2 | Neo-adjuvant (N) | 2015-09-08 | 2015-09-25 | OST Euramos 1 Closed Trial - M | 02 | N | EW EUROEWING 2012 ARM B VDC/IE | 100854380 |
| 190007094 | 190006456 | 1.64 | 98.4 | Palliative (P) | 2019-12-25 | 2020-01-17 | DACTINOMYCIN + IFOSFAMIDE + MESNA + VINCRISTINE | 02 | N | NOT MATCHED | 101125341 |
| 190007112 | 190006457 | 1.52 | 89.7 | null | 2017-03-07 | 2017-03-19 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101211580 |
| 190007202 | 190006458 | 1.59 | 48.8 | Palliative (P) | 2018-06-19 | 2018-07-08 | Cabazitaxel | 02 | N | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 100472873 |
| 190007264 | 190006459 | 1.5 | 66.7 | null | 2021-01-21 | 2021-01-27 | METHOTREXATE | Y | N | METHOTREXATE | 101834705 |
| 190007294 | 190006460 | 1.8 | 71.3 | Palliative (P) | 2019-02-26 | 2019-03-13 | Carboplatin + Etoposide IV 3 day | 02 | N | TRABECTEDIN | 101777522 |
| 190007322 | 190006461 | 1.78 | 95.6 | Palliative (P) | 2018-06-09 | 2018-09-07 | DHAP | 02 | N | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 100427613 |